Researchers Discover Safe Skin Lightening Compound from Skin Bacteria

The compound, cyclo(L-Pro-L-Tyr), shows potential for treating hyperpigmentation with low toxicity, though further research is necessary.

Tokyo University of Science identified cyclo(L-Pro-L-Tyr) from Corynebacterium tuberculostearicum as a potent tyrosinase inhibitor.
Cyclo(L-Pro-L-Tyr) mimics L-tyrosine and blocks tyrosinase activity, reducing melanin production.
The compound is non-toxic to human cells and exhibits antimicrobial, antioxidant, and anticancer properties.
Researchers successfully extracted large quantities of the compound, paving the way for industrial-scale production.
Extensive testing and validation are required before the compound can be used in commercial skincare products.